A R

Dr. A R

IRCCS

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in World Journal of Psychiatry
Verified
Journal Article
Open access
ARA R
A R
LALapo Attardo
Lapo Attardo
GGGiulia Gontero
Giulia Gontero
SRSilvia Rollino
Silvia Rollino
EGElisabetta Groppo
Elisabetta Groppo
EGEnrico Granieri
Enrico Granieri
Mood disorder and depressive syndromes represent a common comorbid condition in neurological disorders with a prevalence rate that ranges between 20% and 50% of patients with stroke, epilepsy, multiple sclerosis, and Parkinson’s disease. Notwithstanding, these conditions are often under-diagnosed and under-treated in the clinical practice and negatively affect the functional recovery, the adherence to treatment, the quality of life, and even the mortality risk. In addition, a bidirectional association between depression and neurological disorders may be possible being that depressive syndromes may be considered as a risk factor for certain neurological diseases. Despite the large amount of evidence regarding the effects of music therapy (MT) and other musical interventions on different aspects of neurological disorders, no updated article reviewing outcomes such as mood, emotions, depression, activity of daily living and so on is actually available; for this reason, little is known about the effectiveness of music and MT on these important outcomes in neurological patients. The aim of this article is to provide a narrative review of the current literature on musical interventions and their effects on mood and depression in patients with neurological disorders. Searching on PubMed and PsycInfo databases, 25 studies corresponding to the inclusion criteria have been selected; 11 of them assess the effects of music or MT in Dementia, 9 explore the efficacy on patients with Stroke, and 5 regard other neurological diseases like Multiple Sclerosis, Amyotrophic Lateral Sclerosis/motor neuron disease, Chronic quadriplegia, Parkinson’s Disease, and Acquired Brain dysfunctions. Selected studies are based on relational and rehabilitative music therapy approaches or concern music listening interventions. Most of the studies support the efficacy of MT and other musical interventions on mood, depressive syndromes, and quality of life on neurological patients.

20 August 2015 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
ARA R
A R
DBDaniele Bellandi
Daniele Bellandi
PBPaola Baiardi
Paola Baiardi
MGMarta Gianotti
Marta Gianotti
MUMaria Chiara Ubezio
Maria Chiara Ubezio
MSMarco Stramba‐Badiale
Marco Stramba‐Badiale

30 January 2017 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
ARA R
A R
AZAlberto Zaliani
Alberto Zaliani
PBPaola Baiardi
Paola Baiardi
DBDaniela Bossi
Daniela Bossi
CSCinzia Sguazzin
Cinzia Sguazzin
MIMarcello Imbriani
Marcello Imbriani

31 August 2015 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
ARA R
A R
Music Therapy Interventions in Parkinson’s Disease: The State-of-the-Art

22 May 2015 in International Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
ARA R
A R
OOOsmano Oasi
Osmano Oasi
MGMarta Gianotti
Marta Gianotti
ARAgnese Rossi
Agnese Rossi
KGKarine Goulene
Karine Goulene
MSMarco Stramba-Badiale
Marco Stramba-Badiale
Aim of the study: The aim of this research is to evaluate the effects of active music therapy (MT) based on free-improvisation (relational approach) in addition to speech language therapy (SLT) compared with SLT alone (communicative-pragmatic approach: Promoting Aphasic's Communicative Effectiveness) in stroke patients with chronic aphasia. Materials and methods: The experimental group (n = 10) was randomized to 30 MT individual sessions over 15 weeks in addition to 30 SLT individual sessions while the control group (n = 10) was randomized to only 30 SLT sessions during the same period. Psychological and speech language assessment were made before (T0) and after (T1) the treatments. Results: The study shows a significant improvement in spontaneous speech in the experimental group (Aachener Aphasie subtest: p = 0.020; Cohen's d = 0.35); the 50% of the experimental group showed also an improvement in vitality scores of Short Form Health Survey (chi-square test = 4.114; p = 0.043). Conclusions: The current trial highlights the possibility that the combined use of MT and SLT can lead to a better result in the rehabilitation of patients with aphasia than SLT alone.

30 March 2019 in BMJ Open
Verified
Journal Article
Open access
PDF file
CGChristian Gold
Christian Gold
Jasmin EickholtJasmin Eickholt
Jasmin Eickholt
JAJörg Assmus
Jörg Assmus
BSBrynjulf Stige
Brynjulf Stige
JWJo Dugstad Wake
Jo Dugstad Wake
MGMonika Geretsegger
Monika Geretsegger
Introduction In older adults, dementia and depression are associated with individual distress and high societal costs. Music interventions such as group music therapy (GMT) and recreational choir singing (RCS) have shown promising effects, but their comparative effectiveness across clinical subgroups is unknown. This trial aims to determine effectiveness of GMT, RCS and their combination for care home residents and to examine heterogeneity of treatment effects across subgroups. Methods and analysis This large, pragmatic, multinational cluster-randomised controlled trial with a 2×2 factorial design will compare the effects of GMT, RCS, both or neither, for care home residents aged 65 years or older with dementia and depressive symptoms. We will randomise 100 care home units with ≥1000 residents in total across eight countries. Each intervention will be offered for 6 months (3 months 2 times/week followed by 3 months 1 time/week), with extension allowed if locally available. The primary outcome will be the change in the Montgomery-Åsberg Depression Rating Scale score at 6 months. Secondary outcomes will include depressive symptoms, cognitive functioning, neuropsychiatric symptoms, psychotropic drug use, caregiver burden, quality of life, mortality and costs over at least 12 months. The study has 90% power to detect main effects and is also powered to determine interaction effects with gender, severity and socioeconomic status. Ethics and dissemination Ethical approval has been obtained for one country and will be obtained for all countries. Results will be presented at national and international conferences and published in scientific journals. Trial registration numbers NCT03496675; Pre-results, ACTRN12618000156280.